Previous close | 278.53 |
Open | 270.89 |
Bid | 283.90 x 0 |
Ask | 284.00 x 0 |
Day's range | 278.16 - 286.00 |
52-week range | 253.48 - 325.00 |
Volume | |
Avg. volume | 3,817,812 |
Market cap | 344.939B |
Beta (5Y monthly) | 0.08 |
PE ratio (TTM) | 30.40 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 8.80 (3.16%) |
Ex-dividend date | 22 Nov 2023 |
1y target est | N/A |
Mindray (SZSE: 300760), a global leader in medical devices and solutions, introduces high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The additions have enhanced Mindray's diverse portfolio of cardiac biomarkers for cardiovascular diseases (CVDs) diagnosis and management.